Jenne returns to Ionis

Kyle Jenne has rejoined Ionis Pharmaceuticals Inc. (NASDAQ:IONS), to lead the company’s commercial strategy as EVP, chief global product strategy. Jenne was Ionis’ chief commercial officer for a year until August 2022 and before that worked in commercial roles at Akcea Therapeutics Inc., which Ionis acquired in 2021. His return to Ionis coincides with the departure of Chief Global Product Strategy and Operations Officer Onaiza Cadoret-Manier, who is leaving to pursue another opportunity. 

Cancer company OncoNano Medicine Inc. promoted Kartik Krishnan to CEO and Melissa Paoloni to COO from SVP, corporate development and strategy. Krishnan joined OncoNano as CMO in 2022, becoming president and head of R&D last year. He succeeds Martin Driscoll, who has led the company since January 2021...